Department of Pathology, Kansai Medical University, 2-3-1 Shin-machi, Hirakata, Osaka 573-1191, Japan.
Department of Urology and Andrology, Kansai Medical University, 2-3-1 Shin-machi, Hirakata, Osaka 573-1191, Japan.
Hum Pathol. 2023 Jan;131:68-78. doi: 10.1016/j.humpath.2022.11.004. Epub 2022 Nov 11.
We have recently shown that histological phenotypes focusing on clear and eosinophilic cytoplasm in clear cell renal cell carcinoma (ccRCC) correlated with prognosis and the response to angiogenesis inhibition and checkpoint blockade. This study aims to objectively show the diagnostic utility of clear or eosinophilic phenotypes of ccRCC by developing an artificial intelligence (AI) model using the TCGA-ccRCC dataset and to demonstrate if the clear or eosinophilic predicted phenotypes correlate with pathological factors and gene signatures associated with angiogenesis and cancer immunity. Before the development of the AI model, histological evaluation using hematoxylin and eosin whole-slide images of the TCGA-ccRCC cohort (n = 435) was performed by a urologic pathologist. The AI model was developed as follows. First, the highest-grade area on each whole slide image was captured for image processing. Second, the selected regions were cropped into tiles. Third, the AI model was trained using transfer learning on a deep convolutional neural network, and clear or eosinophilic predictions were scaled as AI scores. Next, we verified the AI model using a validation cohort (n = 95). Finally, we evaluated the accuracy of the prognostic predictions of the AI model and revealed that the AI model detected clear and eosinophilic phenotypes with high accuracy. The AI model stratified the patients' outcomes, and the predicted eosinophilic phenotypes correlated with adverse clinicopathological characteristics and high immune-related gene signatures. In conclusion, the AI-based histologic subclassification accurately predicted clear or eosinophilic phenotypes of ccRCC, allowing for consistently reproducible stratification for prognostic and therapeutic stratification.
我们最近表明,在透明细胞肾细胞癌(ccRCC)中,聚焦于透明和嗜酸性细胞质的组织学表型与预后以及对血管生成抑制和检查点阻断的反应相关。本研究旨在通过使用 TCGA-ccRCC 数据集开发人工智能(AI)模型来客观地展示 ccRCC 的透明或嗜酸性表型的诊断效用,并证明透明或嗜酸性预测表型是否与与血管生成和癌症免疫相关的病理因素和基因特征相关。在开发 AI 模型之前,由泌尿科病理学家对 TCGA-ccRCC 队列(n=435)的苏木精和伊红全幻灯片图像进行了组织学评估。AI 模型的开发如下。首先,在每个全幻灯片图像上捕获最高等级区域进行图像处理。其次,选择的区域被裁剪成瓦片。第三,使用转移学习在深度卷积神经网络上训练 AI 模型,并将透明或嗜酸性预测值缩放为 AI 得分。接下来,我们使用验证队列(n=95)验证了 AI 模型。最后,我们评估了 AI 模型的预后预测的准确性,并表明 AI 模型能够准确地检测透明和嗜酸性表型。AI 模型对患者的结局进行分层,预测的嗜酸性表型与不良临床病理特征和高免疫相关基因特征相关。总之,基于 AI 的组织学分类准确地预测了 ccRCC 的透明或嗜酸性表型,允许对预后和治疗分层进行一致的可重复分层。